Eligi
Med
Base de datos
Seguridad
Sobre EligiMed
Contacto
Contáctenos
Ensayos Clínicos de Enfermedades Infecciosas | EligiMed
Ensayos clínicos
887 ensayos encontrados
Completado
Fase 2
ClinicalTrials.gov
Continued Access to DRV/Rtv in HIV-1 Infected Children and Adolescents (Rollover Patients From C212, C228, C230)
INTERVENTIONAL
Inicio: 13 de oct de 2010
ID: NCT01138605
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study of Remibrutinib (LOU064) to Investigate the Efficacy, Safety and Tolerability for 52 Weeks in Adult Chronic Spontaneous Urticaria (CSU) Patients Inadequately Controlled by H1-antihistamines
INTERVENTIONAL
Inicio: 30 de nov de 2021
ID: NCT05030311
Completado
Fase 2
ClinicalTrials.gov
A Phase II Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 (Anti-Shiga Toxin) in Pediatric Patients With Hemolytic Uremic Syndrome Associated With Shiga Toxin-producing Escherichia Coli Infection
INTERVENTIONAL
Inicio: 6 de oct de 2022
ID: NCT05569746
Completado
ClinicalTrials.gov
Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients
INTERVENTIONAL
Inicio: 27 de jun de 2020
ID: NCT04379037
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)
INTERVENTIONAL
Inicio: 16 de nov de 2011
ID: NCT01484496
Completado
Fase 2
ClinicalTrials.gov
A Phase I/II Study of Invirase® Boosted With Ritonavir in HIV Infected Infants and Children 4 Months to Less Than 6 Years Old
INTERVENTIONAL
Inicio: 1 de jun de 2008
ID: NCT00623597
Completado
ClinicalTrials.gov
Severe Impairment of Solute-Free Water Clearance in Patients With HIV Infection
OBSERVATIONAL
Inicio: 1 de ene de 2010
ID: NCT01869010
Completado
Fase 2
ClinicalTrials.gov
Prospective, Parallel-group, Open-label Randomized Controlled Trial of Four Treatment Regimes for Trichuriasis in Pediatric Patients
INTERVENTIONAL
Inicio: 9 de oct de 2019
ID: NCT04041453
Completado
Fase 4
ClinicalTrials.gov
Linezolid in the Treatment of Subjects With Complicated Skin and Soft Tissue Infections Proven to be Due to Methicillin-Resistant Staphylococcus Aureus
INTERVENTIONAL
Inicio: 1 de oct de 2004
ID: NCT00087490
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Single-Treatment Study to Assess the Safety and Tolerability of Lyophilized Lucinactant in Adults With COVID-19 Associated Acute Lung Injury
INTERVENTIONAL
Inicio: 5 de ene de 2021
ID: NCT04389671
Completado
Fase 2
ClinicalTrials.gov
A Phase II Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 (cαStx1) and 2 (cαStx2) Administered Concomitantly to Children With Shiga Toxin-Producing Bacterial (STPB) Infection and Bloody Diarrhea (SHIGATEC Trial)
INTERVENTIONAL
Inicio: 1 de nov de 2010
ID: NCT01252199
Completado
ClinicalTrials.gov
Randomized, Double-blind, Placebo-controlled Clinical Trial of Convalescent Plasma for the Treatment of COVID-19 Pneumonia With Severity Criteria
INTERVENTIONAL
Inicio: 15 de may de 2020
ID: NCT04383535
Terminado
Fase 3
ClinicalTrials.gov
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) vs Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities.
INTERVENTIONAL
Inicio: 1 de jun de 2014
ID: NCT02202135
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Observer-Blind, Placebo-Controlled, Group-Sequential Study to Determine the Immunogenicity and Safety of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum in Healthy Third-trimester Pregnant Women; and Safety and Efficacy of Maternally Transferred Antibodies in Preventing RSV Disease in Their Infants
INTERVENTIONAL
Inicio: 1 de dic de 2015
ID: NCT02624947
Completado
Fase 3
ClinicalTrials.gov
A Multi-country & Multi-center Study to Assess the Efficacy, Immunogenicity & Safety of Two Doses of GSK Biologicals' Oral Live Attenuated HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants
INTERVENTIONAL
Inicio: 1 de dic de 2003
ID: NCT00139347
Terminado
Fase 2
ClinicalTrials.gov
A Randomized, Double-Blind (Sponsor-Unblinded), Placebo-Controlled, Adaptive Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH3739937 in Treatment-Naïve Adults Living With HIV-1
INTERVENTIONAL
Inicio: 21 de dic de 2023
ID: NCT06061081
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Double-dummy, Multicenter, Multinational Study to Assess the Efficacy and Safety of Orally Administered Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenously Administered Imipenem-cilastatin in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
INTERVENTIONAL
Inicio: 21 de dic de 2023
ID: NCT06059846
Completado
Fase 2
ClinicalTrials.gov
Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma
INTERVENTIONAL
Inicio: 25 de jun de 2020
ID: NCT04468009
Completado
ClinicalTrials.gov
An International Observational Study of Outpatients With SARS-CoV-2 Infection
OBSERVATIONAL
Inicio: 18 de jun de 2020
ID: NCT04385251
Completado
Fase 3
ClinicalTrials.gov
Atazanavir (BMS-232632) for HIV Infected Individuals Completing Atazanavir Clinical Trials: An Extended Access Study
INTERVENTIONAL
Inicio: 1 de oct de 2002
ID: NCT01003990
Anterior
1
...
25
26
27
...
45
Siguiente
Filtros